本頁面由Tiger Trade Technology Pte. Ltd.提供服務

伊諾維奧製藥

1.25
-0.0300-2.34%
盤後1.21-0.0400-3.20%19:42 EDT
成交量:239.29萬
成交額:301.12萬
市值:1.29億
市盈率:-1.21
高:1.31
開:1.30
低:1.23
收:1.28
52周最高:2.72
52周最低:0.5632
股本:1.03億
流通股本:9,578.70萬
量比:0.79
換手率:2.50%
股息:- -
股息率:- -
每股收益(TTM):-1.0338
每股收益(LYR):-1.8117
淨資產收益率:-409.87%
總資產收益率:-84.23%
市淨率:29.45
市盈率(LYR):-0.69

資料載入中...

2026/08/13

重要事件披露

Form 8-K - Current report
2026/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/12

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/31

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/31

重要事件披露

Form 8-K - Current report
2026/07/30

重要事件披露

Form 8-K - Current report
2026/05/23

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/20

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/06

重要事件披露

Form 8-K - Current report
2026/04/02

重要事件披露

Form 8-K - Current report
2026/03/13

重要事件披露

Form 8-K - Current report
2026/03/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/01/27

重要事件披露

Form 8-K - Current report